Literature DB >> 3947276

Cerebrospinal fluid carcinoembryonic antigen in patients with metastatic and nonmetastatic neurological diseases.

A Twijnstra, W J Nooyen, A P van Zanten, A A Hart, B W Ongerboer de Visser.   

Abstract

Cerebrospinal fluid (CSF) carcinoembryonic antigen (CEA) values were determined in 200 patients suffering from various neurological diseases. We found no relationship between CEA levels and age or sex. A positive test was defined as an upper limit of at least 4.0 ng/mL of CEA. We found raised CSF CEA levels in patients with leptomeningeal spread from carcinoma, but not in patients with leptomeningeal metastases from lymphoma. We also found high values of CSF CEA in three of 21 patients with epidural metastases and in two of 28 patients with cerebral metastases from solid tumors. Comparison was made with the CSF levels of total protein, glucose, and lactate dehydrogenase. The sensitivity of the CSF CEA determination in patients for the presence of leptomeningeal involvement of cancer is 31% and the specificity is 90%.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3947276     DOI: 10.1001/archneur.1986.00520030059015

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  8 in total

1.  CSF protein profiling using Multiplex Immuno-assay: A potential new diagnostic tool for leptomeningeal metastases.

Authors:  Dieta Brandsma; Emile E Voest; Wilco de Jager; Hans Bonfrer; Ale Algra; Willem Boogerd; Tiny Korse; Jaap C Reijneveld; Marcel M Verbeek; Ger Rijkers; Martin J B Taphoorn
Journal:  J Neurol       Date:  2006-09-22       Impact factor: 4.849

2.  LDH isoenzymes in cerebrospinal fluid in various brain tumours.

Authors:  Y Lampl; Y Paniri; Y Eshel; I Sarova-Pinhas
Journal:  J Neurol Neurosurg Psychiatry       Date:  1990-08       Impact factor: 10.154

3.  Cerebrospinal fluid tumour markers in patients treated for meningeal malignancy.

Authors:  A P van Zanten; A Twijnstra; B W Ongerboer de Visser; P van Heerde; A A Hart; W J Nooyen
Journal:  J Neurol Neurosurg Psychiatry       Date:  1991-02       Impact factor: 10.154

Review 4.  The Utility of Liquid Biopsy in Central Nervous System Malignancies.

Authors:  Kathryn S Nevel; Jessica A Wilcox; Lindsay J Robell; Yoshie Umemura
Journal:  Curr Oncol Rep       Date:  2018-06-06       Impact factor: 5.075

5.  Serial lumbar and ventricular cerebrospinal fluid biochemical marker measurements in patients with leptomeningeal metastases from solid and hematological tumors.

Authors:  A Twijnstra; B W Ongerboer de Visser; A P van Zanten; A A Hart; W J Nooyen
Journal:  J Neurooncol       Date:  1989-05       Impact factor: 4.130

6.  Diagnostic value of cerebrospinal fluid level of carcinoembryonic antigen in patients with leptomeningeal carcinomatous metastasis.

Authors:  Sung Jin Kang; Kwang Soo Kim; Yoon Suk Ha; So Young Huh; Ji Hyun Lee; Jong Kuk Kim; Min Jeong Kim
Journal:  J Clin Neurol       Date:  2010-03-26       Impact factor: 3.077

7.  Leptomeningeal carcinomatosis in a patient with gallbladder carcinoma.

Authors:  Nisha Jose; Harsha Teja Perla; Ramya Iyadurai; Geeta Chacko
Journal:  J Cytol       Date:  2017 Apr-Jun       Impact factor: 1.000

8.  A simple method for discrimination of carcinomatous meningitis using CEA, total protein, and total cell count in the cerebrospinal fluid of primary lung cancer patients.

Authors:  Yukari Ogawa; Takeshi Saraya; Akinari Noda; Nozomi Kurokawa; Sho Sakuma; Kaori Aso; Sunao Mikura; Miku Oda; Manabu Ishida; Kojiro Honda; Keitaro Nakamoto; Masaki Tamura; Saori Takata; Haruyuki Ishii; Hajime Takizawa
Journal:  Medicine (Baltimore)       Date:  2021-04-09       Impact factor: 1.817

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.